Apogee Therapeutics, Inc. APGE Unpaid Financing Cost In Accrued Liability
Other financials
Where this comes from
Reported directly by Apogee Therapeutics, Inc. in its filing.
Tagged under the XBRL concept apge:UnpaidFinancingCostInAccruedLiability.
The official record: Apogee Therapeutics, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Apogee Therapeutics, Inc.'s unpaid financing cost in accrued liability.
Connect your AI assistant and see it in context, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Apogee Therapeutics, Inc.'s unpaid financing cost in accrued liability?
- Apogee Therapeutics, Inc. (APGE) reported unpaid financing cost in accrued liability of $728K in Q1 2026.